CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer Vaccine

Overview of attention for article published in Drug Design, Development and Therapy, September 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 2 X users

patent: 3 patents

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 987 followers.

CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer Vaccine https://t.co/CjlrGfqlig

27 Sep 2021

Reply Repost Favourite

New article: CpG Oligodeoxynucleotide Developed to Activate Primate Immune Responses Promotes Antitumoral Effects in Combination with a Neoantigen-Based mRNA Cancer Vaccine https://t.co/XVau9kwMFK #melanoma #oncology https://t.co/iM2VkrUwbb